We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
ImmunoGenesis, a clinical-stage biotechnology company developing immune therapies, has appointed seasoned industry veterans to key roles to support the expansion of the company's R&D, clinical and business development activities.
ProBioGen AG today announced that Immunogenesis, Inc., a spin-off of the MD Anderson Cancer Center, University of Texas, has signed a Service Agreement for Cell Line Development, Process Development and GMP Manufacturing in 1,000 L bioreactor scale for th